nasal spray – Dr. Barry Dworkin

UBC, Université de Sherbrooke, and Cornell University researchers report a new enzyme-blocking compound delivered in a nasal spray that effectively treats delta variant infection in mice. Human trials dependent on securing funding.

March 29, 2022

Medical Mythbusting Commentary for March 29, 2022 Source:New compound delivered in a nasal spray effectively treats delta variant infection in mice Reference:A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic

UBC, Université de Sherbrooke, and Cornell University researchers report a new enzyme-blocking compound delivered in a nasal spray that effectively treats delta variant infection in mice. Human trials dependent on securing funding.